Position in LLY
as of Mar 31, 2026
· filed May 12, 2026
Position Value
$1,043,647,381
-$526,314,087 QoQ
Shares Held
1,134,683
-22.3% QoQ
Ownership
0.120%
of shares outstanding
% of Portfolio
1.31%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 0%
Shared 54%
None 46%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026VOYA INVESTMENT MANAGEMENT LLC holds $4,074,118,286 across 14 Drug Manufacturers - General names. LLY ranks #1 (25.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
This page
|
1,134,683 | $1,043,647,381 | |
| 2 | JNJ |
Johnson & Johnson
|
3,677,872 | $899,019,031 | |
| 3 | MRK |
Merck & Co., Inc.
|
5,159,124 | $620,591,025 | |
| 4 | GILD |
Gilead Sciences, Inc.
|
3,052,813 | $425,470,547 | |
| 5 | ABBV |
AbbVie Inc.
|
1,780,456 | $387,231,375 | |
| 6 | AZN |
Astrazeneca PLC
|
1,869,864 | $368,774,577 | |
| 7 | PFE |
Pfizer Inc
|
6,450,240 | $181,122,738 | |
| 8 | AMGN |
Amgen Inc
|
223,583 | $78,667,677 |
All Filings in LLY
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,043,647,381 | 1,134,683 | Shares | Defined | 2026-05-12 | |
| 2025-12-31 | $1,569,961,468 | 1,460,864 | Shares | Defined | 2026-02-12 | |
| 2025-09-30 | $595,557,361 | 780,547 | Shares | Defined | 2025-10-09 | |
| 2025-06-30 | $937,678,707 | 1,202,877 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $1,247,293,410 | 1,510,205 | Shares | Defined | 2025-06-18 | |
| 2024-12-31 | $1,097,041,336 | 1,421,038 | Shares | Defined | 2025-05-02 | |
| 2024-09-30 | $974,431,230 | 1,099,884 | Shares | Defined | 2025-02-07 | |
| 2024-06-30 | $1,258,987,022 | 1,390,562 | Shares | Defined | 2025-02-07 | |
| 2024-03-31 | $995,574,859 | 1,279,725 | Shares | Defined | 2025-02-07 | |
| 2023-12-31 | $713,251,584 | 1,223,584 | Shares | Defined | 2025-02-07 | |
| 2023-09-30 | $844,233,539 | 1,571,749 | Shares | Defined | 2025-02-07 | |
| 2023-06-30 | $742,582,931 | 1,583,400 | Shares | Defined | 2025-02-07 | |
| 2023-03-31 | $776,726,062 | 2,261,738 | Shares | Defined | 2025-02-07 | |
| 2022-12-31 | $1,137,753,253 | 3,109,975 | Shares | Defined | 2025-02-07 | |
| 2022-09-30 | $1,006,599,219 | 3,113,033 | Shares | Defined | 2025-02-07 | |
| 2022-06-30 | $575,939,150 | 1,776,329 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $665,338,884 | 2,323,354 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $683,060,293 | 2,472,885 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $604,387,520 | 2,615,830 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $559,765,309 | 2,438,852 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $628,461,544 | 3,363,995 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $577,154,887 | 3,418,354 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $336,676,669 | 2,274,535 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $383,605,255 | 2,336,492 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $274,215,313 | 1,976,754 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||